Coronavirus disease 2019 (COVID-19) : A literature review
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved..
In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally. Perceived risk of acquiring disease has led many governments to institute a variety of control measures. We conducted a literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic. In this literature review, the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed.
| Errataetall: |
CommentIn: Intern Emerg Med. 2020 Nov;15(8):1595-1597. - PMID 32737837 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of infection and public health - 13(2020), 5 vom: 01. Mai, Seite 667-673 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Harapan, Harapan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV |
|---|
| Anmerkungen: |
Date Completed 05.05.2020 Date Revised 13.11.2023 published: Print-Electronic CommentIn: Intern Emerg Med. 2020 Nov;15(8):1595-1597. - PMID 32737837 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jiph.2020.03.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309248795 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309248795 | ||
| 003 | DE-627 | ||
| 005 | 20231225133507.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jiph.2020.03.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1030.xml |
| 035 | |a (DE-627)NLM309248795 | ||
| 035 | |a (NLM)32340833 | ||
| 035 | |a (PII)S1876-0341(20)30432-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Harapan, Harapan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus disease 2019 (COVID-19) |b A literature review |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.05.2020 | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Intern Emerg Med. 2020 Nov;15(8):1595-1597. - PMID 32737837 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally. Perceived risk of acquiring disease has led many governments to institute a variety of control measures. We conducted a literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic. In this literature review, the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Novel coronavirus | |
| 650 | 4 | |a Outbreak | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Itoh, Naoya |e verfasserin |4 aut | |
| 700 | 1 | |a Yufika, Amanda |e verfasserin |4 aut | |
| 700 | 1 | |a Winardi, Wira |e verfasserin |4 aut | |
| 700 | 1 | |a Keam, Synat |e verfasserin |4 aut | |
| 700 | 1 | |a Te, Haypheng |e verfasserin |4 aut | |
| 700 | 1 | |a Megawati, Dewi |e verfasserin |4 aut | |
| 700 | 1 | |a Hayati, Zinatul |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, Abram L |e verfasserin |4 aut | |
| 700 | 1 | |a Mudatsir, Mudatsir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of infection and public health |d 2008 |g 13(2020), 5 vom: 01. Mai, Seite 667-673 |w (DE-627)NLM200240730 |x 1876-035X |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2020 |g number:5 |g day:01 |g month:05 |g pages:667-673 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jiph.2020.03.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2020 |e 5 |b 01 |c 05 |h 667-673 | ||